1.A Synthetic Chenodeoxycholic Acid Derivative, HS-1200-induced Apoptosis of RBL-2H3 Cells.
Byung Chan KOO ; Jeong Soo KIM ; Hyun Ho KWAK ; In Ryoung KIM ; Seung Eun LEE ; Gyoo Cheon KIM ; Hongsuk SUH ; Bong Soo PARK
Korean Journal of Anatomy 2009;42(1):19-30
Bile acids and synthetic bile acid derivatives induced apoptosis in various kinds of cancer cells and anticancer effects. Although synthetic chenodeoxycholic acid (CDCA) derivatives have been demonstrated to induce apoptosis of various cancer cells, there is no report on their effect on RBL-2H3 basophilic leukemia cell line to date. Therefore, this study was undertaken to examine in vitro effects of cytotoxicity and growth inhibition, and the molecular mechanism underlying induction of apoptosis in RBL-2H3 cells treated with a synthetic CDCA derivative, HS-1200. The viability and the growth inhibition of RBL-2H3 cells were assessed by MTT assay and clonogenic assay respectively. The Hoechst staining and DNA electrophoresis were conducted to observe RBL-2H3 cells undergoing apoptosis. RBL-2H3 cells were treated with HS-1200, and Western blotting, immunocytochemistry, confocal microscopy, DNA hypoploidy assay, MMP activity and proteasome activity were performed. HS-1200 treatment of RBL-2H3 cells resulted in a time- and does-dependent decrease of cell viability and a does-dependent inhibition of cell growth, and induced apoptotic cell death. Furthermore, HS-1200 treatment result in the alteration of G1 cell cycle-related proteins. And tested RBL-2H3 cells showed several lines of apoptotic manifestation.We presented data indicating that HS-1200 induces apoptois via the proteasome, mitochondria and caspase pathway, and induces the alteration of the G1 cell cycle-related proteins in RBL-2H3 cells. Therefore our data provide the possibility that HS-1200 could be as a novel therapeutic strategy in the allergy treatment.
Apoptosis
;
Basophils
;
Bile
;
Bile Acids and Salts
;
Blotting, Western
;
Cell Death
;
Cell Line
;
Cell Survival
;
Chenodeoxycholic Acid
;
DNA
;
Electrophoresis
;
Hypersensitivity
;
Immunohistochemistry
;
Leukemia
;
Microscopy, Confocal
;
Mitochondria
;
Proteasome Endopeptidase Complex
;
Proteins
2.Apoptotic Effect of Co-Treatment with a Natural Product, Chios Gum Mastic, and a Synthetic Chenodeoxycholic Acid Derivative, HS-1200, on Human Osteosarcoma Cells.
Ji Hak MIN ; Min Jeong KIM ; In Ryoung KIM ; Seung Eun LEE ; Hyun Ho KWAK ; Gyoo Cheon KIM ; Hae Ryoun PARK ; Sang Hun SHIN ; Chul Hoon KIM ; Na Young JEONG ; Hongsuk SUH ; Bong Soo PARK
Korean Journal of Physical Anthropology 2008;21(2):167-180
Chios gum mastic (CGM) is a resinous exudate obtained from the stem and the main leaves of Pistacia lenticulus tree native to Mediterranean areas. Recently it reported that CGM induced apoptosis in a few cancer cells in vitro. It has been reported that the synthetic chenodeoxycholic acid (CDCA) derivatives showed apoptosis-inducing activity on various cancer cells in vitro. This study was undertaken to investigate the synergistic apoptotic effect of co-treatment with a natural product, CGM and a CDCA derivative, HS-1200 on human osteosarcoma (HOS) cells. To investigate whether the co-treatment of CGM and HS-1200 compared with each single treatment efficiently reduced the viability of HOS cells, MTT assay was conducted. Induction and augmentation of apoptosis were confirmed by DNA electrophoresis, Hoechst staining and DNA hypoploidy, Westen blot analysis and immunofluorescent staining were performed to study the alterations of the expression level and translocation of apoptosis-related proteins in co-treatment. Furthermore, proteasome activity and mitochondrial membrane potential (MMP) change were also assayed. In this study, HOS cells co-treated with CGM and HS-1200 showed several lines of apoptotic manifestation whereas each single treated HOS cells did not. Although the single treatment of 40 microgram/mL CGM or 25 micrometer HS-1200 for 24 h did not induce apoptosis, the cotreatment of them induced prominently apoptosis. Therefore our data provide the possibility that combination therapy of CGM and HS-1200 could be considered as a novel therapeutic strategy for human osteosarcoma.
Apoptosis
;
Chenodeoxycholic Acid
;
DNA
;
Electrophoresis
;
Exudates and Transudates
;
Gingiva
;
Humans
;
Membrane Potential, Mitochondrial
;
Osteosarcoma
;
Pistacia
;
Proteasome Endopeptidase Complex
;
Proteins
;
Resins, Plant
;
Trees